Description

The Chordoma Foundation offers the Impact Grant in partnership with the Cancer Research Institute (CRI) to accelerate innovative immunotherapy research in chordoma. In its eighth consecutive year, the partnership supports chordoma-focused immunology projects involving preclinical and translational research into new immunotherapy approaches.

The grant sits alongside the Foundation’s broader research resources and collaborative support. These include disease models, biospecimens, sequencing and chordoma-omics data, experimental protocols, and preclinical research capabilities. Researchers can discuss support ranging from basic data generation to integrated collaboration with the Foundation’s research team. These resources complement the funding opportunity rather than constitute additional application requirements.